1. Home
  2. TECH vs CMA Comparison

TECH vs CMA Comparison

Compare TECH & CMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • CMA
  • Stock Information
  • Founded
  • TECH 1976
  • CMA 1849
  • Country
  • TECH United States
  • CMA United States
  • Employees
  • TECH N/A
  • CMA N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • CMA Major Banks
  • Sector
  • TECH Health Care
  • CMA Finance
  • Exchange
  • TECH Nasdaq
  • CMA Nasdaq
  • Market Cap
  • TECH 7.8B
  • CMA 7.1B
  • IPO Year
  • TECH 1989
  • CMA N/A
  • Fundamental
  • Price
  • TECH $46.78
  • CMA $56.17
  • Analyst Decision
  • TECH Buy
  • CMA Hold
  • Analyst Count
  • TECH 10
  • CMA 20
  • Target Price
  • TECH $73.44
  • CMA $61.55
  • AVG Volume (30 Days)
  • TECH 2.3M
  • CMA 1.3M
  • Earning Date
  • TECH 05-07-2025
  • CMA 07-18-2025
  • Dividend Yield
  • TECH 0.68%
  • CMA 5.05%
  • EPS Growth
  • TECH N/A
  • CMA 4.95
  • EPS
  • TECH 0.83
  • CMA 5.29
  • Revenue
  • TECH $1,208,770,000.00
  • CMA $3,234,000,000.00
  • Revenue This Year
  • TECH $7.16
  • CMA $7.20
  • Revenue Next Year
  • TECH $6.36
  • CMA $3.01
  • P/E Ratio
  • TECH $56.36
  • CMA $10.63
  • Revenue Growth
  • TECH 4.72
  • CMA N/A
  • 52 Week Low
  • TECH $46.01
  • CMA $45.32
  • 52 Week High
  • TECH $83.96
  • CMA $73.45
  • Technical
  • Relative Strength Index (RSI)
  • TECH 39.97
  • CMA 49.43
  • Support Level
  • TECH $46.05
  • CMA $57.70
  • Resistance Level
  • TECH $49.92
  • CMA $59.13
  • Average True Range (ATR)
  • TECH 2.20
  • CMA 1.08
  • MACD
  • TECH -0.04
  • CMA -0.02
  • Stochastic Oscillator
  • TECH 8.74
  • CMA 35.43

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About CMA Comerica Incorporated

With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.

Share on Social Networks: